OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2001

Schlagwörter:	Tumour Growth Brain Tumour Ranes Untreated Mouse Human Brain Tumour

Anmerkung:	© Adis International Ltd 2001

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1294(2001), 1 vom: Juni, Seite 9-9
Übergeordnetes Werk:	volume:1294 ; year:2001 ; number:1 ; month:06 ; pages:9-9

Links:	Volltext

DOI / URN:	10.2165/00128413-200112940-00018

Katalog-ID:	SPR036344257

Internformat


LEADER	01000caa a22002652 4500
001	SPR036344257
003	DE-627
005	20230519235609.0
007	cr uuu---uuuuu
008	201007s2001 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200112940-00018 \|2 doi
035			\|a (DE-627)SPR036344257
035			\|a (SPR)00128413-200112940-00018-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth
264		1	\|c 2001
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2001
650		4	\|a Tumour Growth \|7 (dpeaa)DE-He213
650		4	\|a Brain Tumour \|7 (dpeaa)DE-He213
650		4	\|a Ranes \|7 (dpeaa)DE-He213
650		4	\|a Untreated Mouse \|7 (dpeaa)DE-He213
650		4	\|a Human Brain Tumour \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1294(2001), 1 vom: Juni, Seite 9-9 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1294 \|g year:2001 \|g number:1 \|g month:06 \|g pages:9-9
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200112940-00018 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1294 \|j 2001 \|e 1 \|c 06 \|h 9-9

Indexfelder

matchkey_str	article:22306056:2001----::g98btlexnjrmcninfcnlih
hierarchy_sort_str	2001
publishDate	2001
allfields	10.2165/00128413-200112940-00018 doi (DE-627)SPR036344257 (SPR)00128413-200112940-00018-e DE-627 ger DE-627 rakwb eng OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth 2001 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2001 Tumour Growth (dpeaa)DE-He213 Brain Tumour (dpeaa)DE-He213 Ranes (dpeaa)DE-He213 Untreated Mouse (dpeaa)DE-He213 Human Brain Tumour (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1294(2001), 1 vom: Juni, Seite 9-9 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1294 year:2001 number:1 month:06 pages:9-9 https://dx.doi.org/10.2165/00128413-200112940-00018 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1294 2001 1 06 9-9
spelling	10.2165/00128413-200112940-00018 doi (DE-627)SPR036344257 (SPR)00128413-200112940-00018-e DE-627 ger DE-627 rakwb eng OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth 2001 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2001 Tumour Growth (dpeaa)DE-He213 Brain Tumour (dpeaa)DE-He213 Ranes (dpeaa)DE-He213 Untreated Mouse (dpeaa)DE-He213 Human Brain Tumour (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1294(2001), 1 vom: Juni, Seite 9-9 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1294 year:2001 number:1 month:06 pages:9-9 https://dx.doi.org/10.2165/00128413-200112940-00018 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1294 2001 1 06 9-9
allfields_unstemmed	10.2165/00128413-200112940-00018 doi (DE-627)SPR036344257 (SPR)00128413-200112940-00018-e DE-627 ger DE-627 rakwb eng OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth 2001 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2001 Tumour Growth (dpeaa)DE-He213 Brain Tumour (dpeaa)DE-He213 Ranes (dpeaa)DE-He213 Untreated Mouse (dpeaa)DE-He213 Human Brain Tumour (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1294(2001), 1 vom: Juni, Seite 9-9 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1294 year:2001 number:1 month:06 pages:9-9 https://dx.doi.org/10.2165/00128413-200112940-00018 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1294 2001 1 06 9-9
allfieldsGer	10.2165/00128413-200112940-00018 doi (DE-627)SPR036344257 (SPR)00128413-200112940-00018-e DE-627 ger DE-627 rakwb eng OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth 2001 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2001 Tumour Growth (dpeaa)DE-He213 Brain Tumour (dpeaa)DE-He213 Ranes (dpeaa)DE-He213 Untreated Mouse (dpeaa)DE-He213 Human Brain Tumour (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1294(2001), 1 vom: Juni, Seite 9-9 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1294 year:2001 number:1 month:06 pages:9-9 https://dx.doi.org/10.2165/00128413-200112940-00018 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1294 2001 1 06 9-9
allfieldsSound	10.2165/00128413-200112940-00018 doi (DE-627)SPR036344257 (SPR)00128413-200112940-00018-e DE-627 ger DE-627 rakwb eng OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth 2001 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2001 Tumour Growth (dpeaa)DE-He213 Brain Tumour (dpeaa)DE-He213 Ranes (dpeaa)DE-He213 Untreated Mouse (dpeaa)DE-He213 Human Brain Tumour (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1294(2001), 1 vom: Juni, Seite 9-9 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1294 year:2001 number:1 month:06 pages:9-9 https://dx.doi.org/10.2165/00128413-200112940-00018 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1294 2001 1 06 9-9
language	English
source	Enthalten in Inpharma weekly 1294(2001), 1 vom: Juni, Seite 9-9 volume:1294 year:2001 number:1 month:06 pages:9-9
sourceStr	Enthalten in Inpharma weekly 1294(2001), 1 vom: Juni, Seite 9-9 volume:1294 year:2001 number:1 month:06 pages:9-9
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Tumour Growth Brain Tumour Ranes Untreated Mouse Human Brain Tumour
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2001-06-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR036344257
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036344257</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519235609.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2001 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200112940-00018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036344257</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200112940-00018-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2001</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2001</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumour Growth</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Brain Tumour</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ranes</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Untreated Mouse</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human Brain Tumour</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1294(2001), 1 vom: Juni, Seite 9-9</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1294</subfield><subfield code="g">year:2001</subfield><subfield code="g">number:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:9-9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200112940-00018</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1294</subfield><subfield code="j">2001</subfield><subfield code="e">1</subfield><subfield code="c">06</subfield><subfield code="h">9-9</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth Tumour Growth (dpeaa)DE-He213 Brain Tumour (dpeaa)DE-He213 Ranes (dpeaa)DE-He213 Untreated Mouse (dpeaa)DE-He213 Human Brain Tumour (dpeaa)DE-He213
topic	misc Tumour Growth misc Brain Tumour misc Ranes misc Untreated Mouse misc Human Brain Tumour
spellingShingle	misc Tumour Growth misc Brain Tumour misc Ranes misc Untreated Mouse misc Human Brain Tumour OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth
topic_unstemmed	misc Tumour Growth misc Brain Tumour misc Ranes misc Untreated Mouse misc Human Brain Tumour
topic_browse	misc Tumour Growth misc Brain Tumour misc Ranes misc Untreated Mouse misc Human Brain Tumour
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth
ctrlnum	(DE-627)SPR036344257 (SPR)00128413-200112940-00018-e
title_full	OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2001
contenttype_str_mv	txt
container_start_page	9
container_volume	1294
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200112940-00018
title_sort	ogt 918 [n-butyldeoxynojirimycin] `significantly inhibited' tumour growth
title_auth	OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth
abstract	© Adis International Ltd 2001
abstractGer	© Adis International Ltd 2001
abstract_unstemmed	© Adis International Ltd 2001
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth
url	https://dx.doi.org/10.2165/00128413-200112940-00018
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200112940-00018
up_date	2024-07-03T17:04:14.991Z
_version_	1803578250355539968
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036344257</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519235609.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2001 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200112940-00018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036344257</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200112940-00018-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2001</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2001</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumour Growth</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Brain Tumour</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ranes</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Untreated Mouse</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human Brain Tumour</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1294(2001), 1 vom: Juni, Seite 9-9</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1294</subfield><subfield code="g">year:2001</subfield><subfield code="g">number:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:9-9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200112940-00018</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1294</subfield><subfield code="j">2001</subfield><subfield code="e">1</subfield><subfield code="c">06</subfield><subfield code="h">9-9</subfield></datafield></record></collection>
score	7.3999968

Nicht das Richtige dabei?

Schreiben Sie uns!

OGT 918 [N-butyldeoxynojirimycin] `significantly inhibited' tumour growth

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?